Abstract
Mycobacterial infections (particularly, tuberculosis caused by Mycobacterium tuberculosis) represent a significant threat to public health, especially south of the Sahara. The problem has been compounded by poor patient compliance due to long periods of treatment, thus resulting in the development of multi-drug resistant (MDR) and extremely drugresistant (XDR) forms the of bacterium. It has, therefore, become imperative to seek new drugs from unexplored sources against these infections. Natural products, from ancient times, have often been used as drugs for the treatment of various ailments. They have also served as templates for the design and synthesis of new drugs. In sub-Saharan Africa particularly, ethnobotanical and ethnomedical knowledge of plants has been exploited to manage several different ailments, including tuberculosis. Thus research efforts have often been concentrated on plants as a source of treatment of diseases as well as drug leads. In this mini review, we report the biological activities of compounds derived from African medicinal plants with the potential for the treatment of anti-mycobacterial infections. Seventy nine (79) antimycobacterial compounds have been identified in sub-Sahara Africa covering the period from 1995 to 2013.
Keywords: Drug discovery, medicinal plants, mycobacterial infections, natural products, tuberculosis.
Anti-Infective Agents
Title:Potential Natural Antimycobacterial Metabolites from Some Sub-Saharan Medicinal Plants
Volume: 12 Issue: 2
Author(s): Joseph N. Yong and Fidele Ntie-Kang
Affiliation:
Keywords: Drug discovery, medicinal plants, mycobacterial infections, natural products, tuberculosis.
Abstract: Mycobacterial infections (particularly, tuberculosis caused by Mycobacterium tuberculosis) represent a significant threat to public health, especially south of the Sahara. The problem has been compounded by poor patient compliance due to long periods of treatment, thus resulting in the development of multi-drug resistant (MDR) and extremely drugresistant (XDR) forms the of bacterium. It has, therefore, become imperative to seek new drugs from unexplored sources against these infections. Natural products, from ancient times, have often been used as drugs for the treatment of various ailments. They have also served as templates for the design and synthesis of new drugs. In sub-Saharan Africa particularly, ethnobotanical and ethnomedical knowledge of plants has been exploited to manage several different ailments, including tuberculosis. Thus research efforts have often been concentrated on plants as a source of treatment of diseases as well as drug leads. In this mini review, we report the biological activities of compounds derived from African medicinal plants with the potential for the treatment of anti-mycobacterial infections. Seventy nine (79) antimycobacterial compounds have been identified in sub-Sahara Africa covering the period from 1995 to 2013.
Export Options
About this article
Cite this article as:
Yong N. Joseph and Ntie-Kang Fidele, Potential Natural Antimycobacterial Metabolites from Some Sub-Saharan Medicinal Plants, Anti-Infective Agents 2014; 12 (2) . https://dx.doi.org/10.2174/2211352512666140417002335
DOI https://dx.doi.org/10.2174/2211352512666140417002335 |
Print ISSN 2211-3525 |
Publisher Name Bentham Science Publisher |
Online ISSN 2211-3533 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Genetic Polymorphism of Organic Anion and Cation Transporters: Pharmacokinetic and Pharmacodynamic Consequences in Pharmacotherapy
Current Pharmacogenomics Hyperglycaemia and Vitamin D: A Systematic Overview
Current Diabetes Reviews Alternative Nucleophilic Residues in Intein Catalysis of Protein Splicing
Protein & Peptide Letters Recent Advances in the Synthesis and Development of Curcumin, its Combinations and Formulations and Curcumin-like Compounds as Anti-infective Agents
Current Medicinal Chemistry Pharmacogenetics: Relevance to African Healthcare
Current Pharmacogenomics and Personalized Medicine Pediatric Immune Dysfunction and Health Risks Following Early-Life Immune Insult
Current Pediatric Reviews Synthesis, Characterization, Biological Activity and Voltammetric Behavior and Determination of Cefaclor Metal Complexes
Current Analytical Chemistry Pharmacological Targeting of the Inflamed Intestinal Barrier
Current Pharmaceutical Design Editorial (Thematic Issue: Nanotechnology for Drug Delivery: Part I)
Current Pharmaceutical Design Virtual Screening of Drugs: Score Functions, Docking, and Drug Design
Current Computer-Aided Drug Design Predicting Targeted Polypharmacology for Drug Repositioning and Multi- Target Drug Discovery
Current Medicinal Chemistry Meet Our Associate Editor
Anti-Cancer Agents in Medicinal Chemistry Synthesis and Pharmacological Activities of Oxadiazole and Pyrimidine Bearing Thiocoumarin Derivatives
Current Microwave Chemistry New insights on Ethambutol Targets in Mycobacterium tuberculosis
Infectious Disorders - Drug Targets Does the Immune System Regulate Mood to Defend against Infection? Evidence from Studies of Immune Factors, Depression, and Antidepressants
Current Psychiatry Reviews Adverse Drug Reactions in a Pulmonary Teaching Hospital: Incidence, Pattern, Seriousness, and Preventability
Current Drug Safety Synthesis of Gold Mediated Biocompatible Nanocomposite of Lactone Enriched Fraction from Sahadevi (Vernonia cinerea Lees): An Assessment of Antimalarial Potential
Current Topics in Medicinal Chemistry Nitric Dioxide as Biologically Important Radical and its Role in Molecular Mechanism of Pancreatic Inflammation
Current Pharmaceutical Analysis Nucleotide Second Messenger Signaling as a Target for the Control of Bacterial Biofilm Formation
Current Topics in Medicinal Chemistry Tachykinins and Neuropsychiatric Disorders
Current Drug Targets